| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |